1. Home
  2. OCUL vs BV Comparison

OCUL vs BV Comparison

Compare OCUL & BV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • BV
  • Stock Information
  • Founded
  • OCUL 2006
  • BV 1939
  • Country
  • OCUL United States
  • BV United States
  • Employees
  • OCUL N/A
  • BV N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • BV Business Services
  • Sector
  • OCUL Health Care
  • BV Consumer Discretionary
  • Exchange
  • OCUL Nasdaq
  • BV Nasdaq
  • Market Cap
  • OCUL 1.4B
  • BV 1.5B
  • IPO Year
  • OCUL 2014
  • BV 2018
  • Fundamental
  • Price
  • OCUL $9.16
  • BV $15.65
  • Analyst Decision
  • OCUL Strong Buy
  • BV Buy
  • Analyst Count
  • OCUL 8
  • BV 7
  • Target Price
  • OCUL $16.50
  • BV $16.65
  • AVG Volume (30 Days)
  • OCUL 889.3K
  • BV 429.4K
  • Earning Date
  • OCUL 11-14-2024
  • BV 11-13-2024
  • Dividend Yield
  • OCUL N/A
  • BV N/A
  • EPS Growth
  • OCUL N/A
  • BV N/A
  • EPS
  • OCUL N/A
  • BV 0.20
  • Revenue
  • OCUL $61,442,000.00
  • BV $2,767,100,000.00
  • Revenue This Year
  • OCUL $15.49
  • BV $1.03
  • Revenue Next Year
  • OCUL $13.31
  • BV $1.48
  • P/E Ratio
  • OCUL N/A
  • BV $78.30
  • Revenue Growth
  • OCUL 6.45
  • BV N/A
  • 52 Week Low
  • OCUL $2.05
  • BV $7.10
  • 52 Week High
  • OCUL $11.78
  • BV $18.89
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 34.86
  • BV 38.36
  • Support Level
  • OCUL $10.46
  • BV $15.00
  • Resistance Level
  • OCUL $11.12
  • BV $18.89
  • Average True Range (ATR)
  • OCUL 0.57
  • BV 0.63
  • MACD
  • OCUL -0.22
  • BV -0.17
  • Stochastic Oscillator
  • OCUL 0.60
  • BV 16.71

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature, and the Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

Share on Social Networks: